AKT1 and osteosarcoma: Conversely, other studies highlight the suppression of cellular proliferation, migration, and progression through deactivation of the PI3K/Akt pathway by Hsp90 knockdown or inhibition in colorectal [96], gastric [97], osteosarcoma [98], ovarian [99] and cervical [64] cancers.